Back
Corcept Therapeutics Stock Predictions
Sponsored
CORT
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Buy
62
CORT
Corcept Therapeutics
Last Price:
$52.12
Seasonality Move:
6.53%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--hereCorcept Therapeutics Stock Forecast
-
Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 34.6% based on the past 20 years of stock performance.
-
Corcept Therapeutics has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Corcept Therapeutics Stock Undervalued?The current Corcept Therapeutics [CORT] share price is $50.90. The Score for CORT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 34.6% based on the past 20 years of stock performance.
Corcept Therapeutics Stock Rating
Buy
62
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics overpriced?
-
Corcept Therapeutics has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Corcept Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
62.22
52-Week Low:
20.84
Prediction Charts
Market Cap:
5.3B
Price in USD:
50.90
Volume:
649.9K
Beta:
0.87
Technical Analysis
SMA50:
53.64
SMA100:
45.92
SMA200:
37.06
52-Wk Change:
55.37%
Stock Predictions
-
Is Corcept Therapeutics stock public?Yes, Corcept Therapeutics is a publicly traded company.
-
What is the Corcept Therapeutics stock quote today?The Corcept Therapeutics stock price is 50.90 USD today.
-
How to buy Corcept Therapeutics stock online?You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-4 | 59.82 | 60.85 | 62.22 | 59.53 |
Dec-5 | 59.99 | 59.42 | 60.20 | 59.02 |
Dec-6 | 60.21 | 60.78 | 61.37 | 59.90 |
Dec-9 | 60.81 | 59.26 | 61.19 | 58.02 |
Dec-10 | 59.46 | 58.81 | 60.19 | 58.25 |
Dec-11 | 59.89 | 60.08 | 60.90 | 58.02 |
Dec-12 | 56.08 | 56.33 | 59.92 | 53.51 |
Dec-13 | 57.62 | 55.40 | 58.51 | 55.20 |
Dec-16 | 55.49 | 55.43 | 56.46 | 54.52 |
Dec-17 | 55.26 | 55.14 | 56.13 | 54.14 |
Dec-18 | 54.95 | 52.40 | 55.99 | 52.02 |
Dec-19 | 52.65 | 51.15 | 53.27 | 50.78 |
Dec-20 | 50.58 | 51.43 | 52.35 | 50.02 |
Dec-23 | 51.72 | 50.90 | 51.72 | 49.51 |
Corcept Therapeutics Earnings
Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics Forecast Revenue Growth
Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.32 per share.
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.